Homeopathy-Phosphorus and Cardiac Protection

Homeopathically prepared Phosphorus represents a constitutional and multi-system affecting remedy. It plays a vital role in various clinical and pathological conditions including action on the heart. Considered one of the best polychrests, it is a must part of every physician’s chest box. Phosphorus has been extensively studied from the clinical point of view, as evident from its growing materia medica and clinical uses. At research front too, it is a remedy for experimentation and inferences.

A recent publication by ÉC Ferreira, L Ciupa, AR Portocarrero, CF Brustolin, PF Massini, DL Aleixo and SM de Araújo, titled, “Phosphorus protects cardiac tissue by modifying the immune response in rats infected by Trypanosoma cruzi” published in journal Cytokine 2017 Jul 27, doi: 10.1016/j.cyto.2017.07.017, reports the protective action of potentized (ultra high diluted) Phosphorus in rats.

The Wistar lineage rats, experimentally infected with T. cruzi, treated with Phosphorus 13cH were evaluated for myocarditis focuses and cytokine production. Control group was introduced to tackle bias.

The RESULTS as stated in the study are as follows:
“The animals treated with Phosphorus 13cH had high concentration of INF-ɣ on the 5th day of infection with significant decrease on the 10th and 24th days (p<0.05), and high concentration of TNF-α on the 5th and 10th days of infection with decrease on the 24th day (p<0.05). The treatment with Phosphorus caused a significant increase of INF-ɣ and TNF-α on the 5th day of infection compared with the Control (p<0.05), with reestablishment on the 24th day, as well as in the Control group. The group treated with Phosphorus had 52.5% less number of myocarditis focuses in heart than Control group (p<0.05) on the 10th day of infection. The significant increase in cytokines on the 5th day of infection in the Phosphorus group is related to a significant decrease in the number of inflammatory foci in cardiac tissue on the 10th day of infection in this group.”

This research proposes the consideration of the use of homeopathy in the management of patients with the Chagas disease. 

This can be in conjugation with the clinical practices of homeopathically prepared Phosphorus. Phosphorus has been extensively used in patients with cardiac symptoms such as:

  • Violent palpitation with anxiety, while lying on left side. Pulse rapid, small, and soft. Heart dilated, especially right. Feeling of warmth in the heart. (Homoeopathic Materia Medica by William Boericke)
  • Heart, pains into right arm; violent palpitation from the least thing (Boger Materia Medica)
  • Phosphorus has violent palpitation; worse from motion, and from lying on the left side especially in the evening; worse at night on waking, with orgasms of blood in the chest, accompanied by much suffocation. (Lectures on Homoeopathic Materia Medica by JT Kent).
  • Anxiety about the heart with nausea and a peculiar hunger, somewhat > by eating, distressing even in bed. Sensation of warmth about right side of the heart. Pressure; heaviness; aching in the heart. Rush of blood to heart and palpitation, that becomes very violent after eating. Palpitation of the heart of different kinds, esp. after a meal, morning and evening, as also when seated, and after all kinds of mental excitement. (A dictionary of practical materia medica by JH Clarke).

Therefore, the time has come when we must direct our clinical practice with a pinch of fundamental and scientific research. Research studies that aim to decipher the physiological mechanisms may help us to understand the disease, cure, and health from a deeper point of view. Medicines like Phosphorus must be studied from various aspects so that a correlation between the symptoms, pathologies, and mode of action may be linked in a plausible manner. Similar effects of Phosphorus may be conducted in other clinical conditions and a comparative symptomatology be formed with an understandable physiological phenomenon.

The study may be cited and referred at https://www.ncbi.nlm.nih.gov/pubmed/28757361

IPRH welcomes your valuable opinion!